Navita Khatri, DPM
Podiatrist · Stockbridge, GANPI 1205457348
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,207 of the $4,917 with a category attached, or 65.2%. 6 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 52.8% of the total. 2025 is the largest year on record at $4,344, more than ten times the $136 reported in 2022.
Across 38 payments — averaging $129.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$3K
- Smith+Nephew$2K
- Medline Industries LP$136
- Solventum Corporation$23
- Globus Medical$16
- Bioventus LLC$15
What the payments were for
- Travel & lodging$3,20765%
- Food & beverage$1,70935%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 19 | $2,598 |
| Smith+Nephew | 15 | $2,129 |
| Medline Industries LP | 1 | $136 |
| Solventum Corporation | 1 | $23 |
| Globus Medical | 1 | $16 |
| Bioventus LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PICO$1,836
- LAPIPLASTY SYSTEM 1$1,467
- Grafix$1,371
- Versajet$1,371
- COLLAGENASE SANTYL$1,371
- Lapiplasty$340
- Lapiplasty System$143
- PERCUPLASTY TRAY$136
How this compares
$4,917 in reported general payments places this provider in the 75th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 188 | $3,849 |
| Ammonium Lactate | 174 | $3,539 |
| Ketoconazole | 128 | $1,687 |
| Clotrimazole | 47 | $1,565 |
| Ciclopirox | 46 | $1,084 |
| Diclofenac Sodium | 37 | $774 |
| Doxycycline Hyclate | 52 | $372 |
| Terbinafine Hcl | 23 | $252 |
| Colchicine | 12 | $204 |
| Mupirocin | 28 | $195 |
| Methylprednisolone | 24 | $155 |
| Meloxicam | 54 | $115 |
| Cephalexin | 21 | $74 |
| Tramadol Hcl | 12 | $56 |
| Ciprofloxacin Hcl | 17 | $50 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Stockbridge
- Allen RaphaelSmyrna$324K
- Ira KrausFort Oglethorpe$223K
- Stephen BarrettMarietta$82K
- Mohammad SharifAtlanta$79K
- Craig CamastaAtlanta$49K
- Ryan FitzgeraldCanton$43K
- Margo JimenezAtlanta$19K
- Samantha MinerSmyrna$17K
- Robson SpinolaJesup$15K
- Christopher CorwinJohns Creek$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.